| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |